En español


NIDA Division Director Virtual Seminar Series

NIDA Division Director Virtual Seminar Series Recorded talks introduce the mission, goals, and international research priorities of each NIDA Division. Learn more about NIDA, identify potential research topics of interest to NIDA, or prepare for meetings with NIDA staff.

Promote NIDA International Fellowships

Placing one of our NIDA International Fellowship Program graphics on your Web site allows your visitors to easily click through to our Web site and learn more about the program. Simply copy the HTML embed code provided beside each image, and paste it onto your site where the image should appear. For additional information, please contact ip@nida.nih.gov.

NIDA Hosts Iraqis

The National Institute on Drug Abuse (NIDA) International Program hosted a group of four Iraqis taking part in the Iraq–Substance Abuse and Mental Health Services Administration (SAMHSA) Initiative. In 2008, Iraq and SAMHSA launched the initiative, in which multidisciplinary behavioral health teams from Iraq visit SAMHSA and host sites around the United States to learn about various interventions the teams want to adapt for implementation in Iraq.

Medication Development Researcher Phil Skolnick Leads NIDA Drug Discovery Efforts

Phil Skolnick, Ph.D., D.Sc. (Hon.), a leader in the worlds of corporate and academic drug research, has been appointed director of the NIDA Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA). Dr. Skolnick was previously a research professor of psychiatry at New York University Langone Medical Center. He served as chief scientific officer at DOV Pharmaceutical, Inc., from 2001–2009.

NIH Plans New Institute on Substance Abuse, Use, and Addiction Research

The National Institutes of Health (NIH) recently announced its plans to create a new Institute focusing on substance use, abuse, and addiction research and related public health initiatives. This Institute would integrate the relevant research portfolios from NIDA, the National Institute on Alcohol Abuse and Alcoholism, and other NIH Institutes and Centers. NIH Director Dr.

NIDA Names New Acting Deputy Director

Dr. David Shurtleff was recently named acting deputy director of NIDA. Dr. Shurtleff, who has been director of the Institute’s Division of Basic Neuroscience and Behavioral Research (DBNBR), will assist in developing, implementing, and managing NIDA’s programs, priorities, resources, policies, and research dissemination efforts.

In Memoriam: Charles R. Schuster

It is with sadness that we mourn the death of Dr. Charles R. Schuster, a much admired and respected member of our scientific community and past NIDA director. Dr. Schuster, who died February 21, 2010, was a pioneer in substance abuse and addiction, opening the path to new research approaches that today are promising treatment strategies. He has authored or co-authored more than 200 scientific journal articles, as well as numerous book chapters and several books. Prior to his death, Dr.

New NIDA Grantees Collaborate To Address HIV/AIDS and Drug Use

Late last year, five new research teams began work to address HIV/AIDS and drug use in areas where it is already at epidemic proportions or where it is quickly emerging to become one if efforts are not made to halt or reverse the current momentum. The research projects are the result of NIDA grants designed to stimulate collaborative research among foreign investigators from the same geographic regions to address regional issues on the intersection of HIV/AIDS and drug use in international settings.

NIDA's Mini-Meetings Encourage Research Exchange

NIDA is hosting small meetings in conjunction with larger, more broadly focused conferences to bring together drug abuse and addiction scientists to share research findings and explore potential collaborations. The mini-meetings include:

NIDA, Italian Officials Agree To Cooperate on Drug Abuse Research and Training

NIDA Director Nora D. Volkow, M.D.; Carlo Giovanardi, Undersecretary for the Family, Drugs and Civil Service, Presidency of the Council of Ministers, Italy; and Giovanni Serpelloni, M.D., Department for Anti-drug Policies (DAP), Presidency of the Council of Ministers, Italy, agreed July 25, 2011, to foster mutually beneficial research and research training to improve the diagnosis and treatment of drug abuse and addiction.

The memorandum of understanding cited three research areas of particular interest for the two agencies: